736 related articles for article (PubMed ID: 29705281)
21. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
[TBL] [Abstract][Full Text] [Related]
22. Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.
Choi MH; Kim CK; Lee YJ; Jung SE
AJR Am J Roentgenol; 2019 Apr; 212(4):839-846. PubMed ID: 30779662
[TBL] [Abstract][Full Text] [Related]
23. 1.5-T multiparametric MRI using PI-RADS: a region by region analysis to localize the index-tumor of prostate cancer in patients undergoing prostatectomy.
Reisæter LA; Fütterer JJ; Halvorsen OJ; Nygård Y; Biermann M; Andersen E; Gravdal K; Haukaas S; Monssen JA; Huisman HJ; Akslen LA; Beisland C; Rørvik J
Acta Radiol; 2015 Apr; 56(4):500-11. PubMed ID: 24819231
[TBL] [Abstract][Full Text] [Related]
24. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
Greer MD; Brown AM; Shih JH; Summers RM; Marko J; Law YM; Sankineni S; George AK; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2017 Feb; 45(2):579-585. PubMed ID: 27391860
[TBL] [Abstract][Full Text] [Related]
25. What is the most effective tool for detecting prostate cancer using a standard MR scanner?
Osugi K; Tanimoto A; Nakashima J; Shinoda K; Hashiguchi A; Oya M; Jinzaki M; Kuribayashi S
Magn Reson Med Sci; 2013 Dec; 12(4):271-80. PubMed ID: 24172787
[TBL] [Abstract][Full Text] [Related]
26. Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
Xu L; Zhang G; Shi B; Liu Y; Zou T; Yan W; Xiao Y; Xue H; Feng F; Lei J; Jin Z; Sun H
Cancer Imaging; 2019 Dec; 19(1):90. PubMed ID: 31864408
[TBL] [Abstract][Full Text] [Related]
27. Prediction of biochemical recurrence in prostate cancer patients who underwent prostatectomy using routine clinical prostate multiparametric MRI and decipher genomic score.
Jambor I; Falagario U; Ratnani P; Perez IM; Demir K; Merisaari H; Sobotka S; Haines GK; Martini A; Beksac AT; Lewis S; Pahikkala T; Wiklund P; Nair S; Tewari A
J Magn Reson Imaging; 2020 Apr; 51(4):1075-1085. PubMed ID: 31566845
[TBL] [Abstract][Full Text] [Related]
28. Dynamic contrast-enhanced imaging in localizing local recurrence of prostate cancer after radiotherapy: Limited added value for readers of varying level of experience.
Luzurier A; Jouve De Guibert PH; Allera A; Feldman SF; Conort P; Simon JM; Mozer P; Compérat E; Boudghene F; Servois V; Lucidarme O; Granger B; Renard-Penna R
J Magn Reson Imaging; 2018 Oct; 48(4):1012-1023. PubMed ID: 29517822
[TBL] [Abstract][Full Text] [Related]
29. MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.
Bura V; Caglic I; Snoj Z; Sushentsev N; Berghe AS; Priest AN; Barrett T
Eur Radiol; 2021 Jul; 31(7):4908-4917. PubMed ID: 33398421
[TBL] [Abstract][Full Text] [Related]
30. Prospective comparison of PI-RADS version 2 and qualitative in-house categorization system in detection of prostate cancer.
Gaur S; Harmon S; Mehralivand S; Bednarova S; Calio BP; Sugano D; Sidana A; Merino MJ; Pinto PA; Wood BJ; Shih JH; Choyke PL; Turkbey B
J Magn Reson Imaging; 2018 Nov; 48(5):1326-1335. PubMed ID: 29603833
[TBL] [Abstract][Full Text] [Related]
31. 3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.
Rischke HC; Nestle U; Fechter T; Doll C; Volegova-Neher N; Henne K; Scholber J; Knippen S; Kirste S; Grosu AL; Jilg CA
Radiat Oncol; 2013 Jul; 8():183. PubMed ID: 23875672
[TBL] [Abstract][Full Text] [Related]
32. Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.
Gaur S; Harmon S; Rosenblum L; Greer MD; Mehralivand S; Coskun M; Merino MJ; Wood BJ; Shih JH; Pinto PA; Choyke PL; Turkbey B
AJR Am J Roentgenol; 2018 Jul; 211(1):W33-W41. PubMed ID: 29733695
[TBL] [Abstract][Full Text] [Related]
33. Comparison of T2-Weighted Imaging, DWI, and Dynamic Contrast-Enhanced MRI for Calculation of Prostate Cancer Index Lesion Volume: Correlation With Whole-Mount Pathology.
Sun C; Chatterjee A; Yousuf A; Antic T; Eggener S; Karczmar GS; Oto A
AJR Am J Roentgenol; 2019 Feb; 212(2):351-356. PubMed ID: 30540213
[TBL] [Abstract][Full Text] [Related]
34. Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.
Harvey H; Orton MR; Morgan VA; Parker C; Dearnaley D; Fisher C; deSouza NM
Br J Radiol; 2017 Mar; 90(1071):20160416. PubMed ID: 28055249
[TBL] [Abstract][Full Text] [Related]
35. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
[TBL] [Abstract][Full Text] [Related]
36. Detection of locally radio-recurrent prostate cancer at multiparametric MRI: Can dynamic contrast-enhanced imaging be omitted?
Alonzo F; Melodelima C; Bratan F; Vitry T; Crouzet S; Gelet A; Rouvière O
Diagn Interv Imaging; 2016 Apr; 97(4):433-41. PubMed ID: 26928245
[TBL] [Abstract][Full Text] [Related]
37. Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary?
Antunes N; Vas D; Sebastia C; Salvador R; Ribal MJ; Nicolau C
Abdom Radiol (NY); 2021 Jul; 46(7):3401-3409. PubMed ID: 33683430
[TBL] [Abstract][Full Text] [Related]
38. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
39. Investigating the role of DCE-MRI, over T2 and DWI, in accurate PI-RADS v2 assessment of clinically significant peripheral zone prostate lesions as defined at radical prostatectomy.
Taghipour M; Ziaei A; Alessandrino F; Hassanzadeh E; Harisinghani M; Vangel M; Tempany CM; Fennessy FM
Abdom Radiol (NY); 2019 Apr; 44(4):1520-1527. PubMed ID: 30361870
[TBL] [Abstract][Full Text] [Related]
40. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]